Do lima beans lower blood pressure?

Lima bean protein hydrolyzates have demonstrated ACE-inhibiting activity in laboratory (in vitro) studies, suggesting a potential mechanism for blood pressure reduction by blocking the conversion of angiotensin I to angiotensin II. However, no human clinical trials have confirmed this effect at any specific dose, so lima beans cannot currently be recommended as a blood pressure treatment based on available evidence.

Are lima beans safe to eat raw?

Raw lima beans contain linamarin, a cyanogenic glycoside that enzymes convert into hydrogen cyanide upon cell disruption; this is particularly concentrated in certain non-domesticated varieties. Thorough boiling destroys both the linamarase enzyme and degrades linamarin, making cooked lima beans safe for consumption; raw or undercooked beans should be strictly avoided.

What antioxidants are in lima beans?

Lima beans contain phenolic compounds, including flavonoids and condensed tannins, whose antioxidant activity has been measured using the TEAC (Trolox equivalent antioxidant capacity) assay. Notably, this antioxidant activity persists after cooking, indicating the relevant phenolic structures are thermally stable, though in vitro TEAC values do not directly confirm equivalent antioxidant effects in the human body.

Can lima beans interact with ACE inhibitor medications?

Because bioactive peptides from lima bean protein hydrolyzates inhibit ACE in vitro via a mechanism similar to pharmaceutical ACE inhibitors like lisinopril, a theoretical additive interaction exists when consuming concentrated extracts alongside these medications. This interaction has not been demonstrated in human subjects, but patients on antihypertensive therapy should inform their healthcare provider before using any concentrated legume peptide supplement.

How much protein do lima beans contain and what makes it bioactive?

Mature dried lima beans contain approximately 20–22 grams of protein per 100 grams dry weight, composed largely of globulin-type storage proteins including legumin and vicilin fractions. When these proteins are hydrolyzed by enzymes such as pepsin, pancreatin, or Alcalase, the resulting peptide fragments exhibit measurable ACE-inhibitory activity in vitro, with inhibitory potency varying based on the specific protease and hydrolysis conditions used.

How much lima bean intake is needed to see potential cardiovascular benefits?

While lima beans contain compounds with ACE-inhibitory activity in laboratory studies, there is no established clinical dosage for cardiovascular support in humans. Most nutritional benefit comes from consuming lima beans as part of a regular diet—typically 1/2 to 1 cup of cooked beans per serving—rather than isolated supplements. Current evidence is limited to in vitro research, so whole-food consumption recommendations rely on general legume intake guidelines rather than specific therapeutic doses.

Are lima beans safe to consume during pregnancy and for young children?

Lima beans are generally safe for pregnant women and children when properly cooked, as they are a nutrient-dense whole food rich in folate and protein. However, raw or undercooked lima beans contain cyanogenic glycosides and should be avoided by all populations; proper cooking destroys these compounds. Pregnant women and young children should consume cooked lima beans in normal dietary amounts, though those with bean sensitivities or digestive concerns should consult a healthcare provider.

Does cooking method affect the polyphenol and antioxidant content of lima beans?

Boiling and cooking preserve significant antioxidant activity in lima beans, with in vitro studies showing measurable TEAC values even after thermal processing. However, the specific polyphenol content (up to 215.57 mg GAE/g) may be partially reduced depending on cooking time and method, as water-based cooking can leach some heat-sensitive compounds. Pressure cooking or minimal-water cooking methods may retain higher polyphenol levels compared to prolonged boiling, though human bioavailability studies are limited.

Phaseolus lunatus (Lima Bean)

Lima bean (Phaseolus lunatus) contains bioactive peptides released during protein hydrolysis that inhibit angiotensin-converting enzyme (ACE), a key regulator of blood pressure. Its seed proteins and phenolic compounds also exhibit measurable antioxidant activity, quantified via TEAC assays, that remains stable through cooking.

Category: Legume Evidence: 2/10 Tier: Emerging

Phaseolus lunatus (Lima Bean) — Hermetica Encyclopedia

Origin & History

Phaseolus lunatus, commonly known as lima bean, is a legume native to Mesoamerica and South America with multiple independent domestication events for small-seeded landraces. It belongs to the Fabaceae family and is typically consumed as whole cooked seeds, recognized by the USDA as a nutrient-dense food rich in proteins, polyphenols, and flavonoids.

Historical & Cultural Context

Historical documentation focuses primarily on P. lunatus as an agricultural food crop with ancient domestication in Mesoamerica rather than medicinal applications. No specific traditional medicinal uses in ethnomedicine systems were identified in the available research.

Health Benefits

• May support cardiovascular health through angiotensin-converting enzyme inhibition (ACEI) activity demonstrated in protein hydrolyzates (in vitro evidence only)
• Provides antioxidant activity measured as TEAC (Trolox equivalent antioxidant capacity) that persists after cooking (in vitro evidence only)
• Enhanced polyphenol content (up to 215.57 mg GAE/g) and flavonoid levels (71.84 mg RE/g) when germinated for 72 hours (laboratory analysis only)
• Protein isolates show emulsifying properties for potential functional food applications (preliminary research)
• Note: No human clinical trials have been conducted on P. lunatus; all evidence is from in vitro or animal studies

How It Works

Protein hydrolyzates derived from Phaseolus lunatus seeds generate bioactive peptides that competitively inhibit angiotensin-converting enzyme (ACE), thereby potentially reducing the conversion of angiotensin I to the vasoconstrictive angiotensin II. Separately, phenolic compounds including flavonoids and condensed tannins present in lima bean seeds scavenge free radicals through hydrogen atom transfer and single electron transfer mechanisms, measured quantitatively as Trolox equivalent antioxidant capacity (TEAC). These antioxidant properties are notably resistant to thermal degradation during standard cooking processes, suggesting structural stability of the relevant phenolic constituents.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Phaseolus lunatus were identified in the available research. The only related human evidence comes from studies on Phaseolus vulgaris (common bean), including a meta-analysis of 6 RCTs showing non-significant weight loss but significant body fat reduction (MD -1.86 kg, 95% CI -3.39 to -0.32), though methodological flaws were noted.

Clinical Summary

Current evidence for lima bean's bioactive properties is derived entirely from in vitro studies; no published human clinical trials have directly tested blood pressure or antioxidant outcomes from Phaseolus lunatus consumption. In vitro ACE inhibition has been demonstrated in enzymatically produced protein hydrolyzates, with inhibitory activity dependent on the specific protease used and degree of hydrolysis. Antioxidant capacity has been quantified via TEAC assays in both raw and cooked seed preparations, confirming persistence of activity after heat treatment, though in vitro antioxidant results do not reliably predict in vivo efficacy. The overall evidence base is preliminary, and extrapolation to human health outcomes requires confirmation through controlled clinical studies.

Nutritional Profile

Lima beans are nutrient-dense legumes with the following approximate composition per 100g dry weight: Protein: 20–23g (containing essential amino acids including leucine ~1.6g, lysine ~1.4g, phenylalanine ~1.1g; moderately low in methionine and cysteine, limiting bioavailability of sulfur-containing amino acids); Total Carbohydrates: 60–65g (predominantly starch ~45–50g, with resistant starch fractions that act as prebiotic substrate); Dietary Fiber: 18–22g (mix of soluble and insoluble fiber, including pectin and hemicellulose); Total Fat: 1.2–1.8g (low lipid content, predominantly unsaturated fatty acids including linoleic acid); Moisture (cooked): ~69g per 100g cooked weight. Key Micronutrients per 100g dry weight — Folate: 395–440 µg (critical for one-carbon metabolism; bioavailability ~50–70% due to polyglutamate forms requiring intestinal hydrolysis); Iron: 6–8mg (non-heme form; bioavailability reduced by phytates, estimated 2–5% absorption; vitamin C co-consumption enhances uptake); Potassium: 1400–1700mg; Magnesium: 180–220mg; Phosphorus: 380–430mg (partially bound as phytate, reducing bioavailability); Zinc: 2.5–3.5mg (bioavailability limited by phytic acid chelation); Manganese: 1.3–1.8mg; Calcium: 55–80mg; Thiamine (B1): 0.5–0.7mg; Riboflavin (B2): 0.18–0.22mg; Niacin (B3): 1.5–2.0mg; Vitamin B6: 0.4–0.6mg. Bioactive Compounds: Total polyphenols: up to 215.57mg GAE/g under enhanced extraction conditions (standard dry bean: ~3–8mg GAE/g); Flavonoids: up to 71.84mg RE/g under enhanced conditions; Specific flavonoids include kaempferol and quercetin glycosides; Condensed tannins (proanthocyanidins) present in seed coat; Phytic acid (inositol hexaphosphate): 1.0–2.5g per 100g dry weight (primary antinutrient reducing mineral bioavailability); Trypsin inhibitors and hemagglutinins (lectins) present in raw beans — substantially inactivated by thorough cooking (boiling ≥30 min); Linamarin (cyanogenic glycoside): present in some varieties, particularly bitter types; degrades significantly upon soaking and cooking to safe levels; Saponins: ~0.5–1.5g per 100g dry weight. Bioavailability Notes: Soaking (8–12 hours) and boiling reduces phytate content by 30–60% and lectin activity by >90%, significantly improving mineral and protein digestibility; Protein digestibility-corrected amino acid score (PDCAAS) estimated at 0.5–0.7 for cooked lima beans; Antioxidant activity measured as TEAC persists after cooking, indicating heat-stable polyphenol fraction; Resistant starch content increases upon cooling cooked beans, benefiting gut microbiome.

Preparation & Dosage

No clinically studied dosage ranges for P. lunatus extracts, powders, or standardized forms have been established due to absence of human trials. In food applications, protein hydrolyzates have been added to pasta at unspecified levels while retaining bioactivity. Traditional consumption involves cooking whole beans to mitigate raw seed toxicity. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other legume proteins, vitamin C (for iron absorption), digestive enzymes, antioxidant compounds, ACE-inhibiting peptides

Safety & Interactions

Raw lima beans contain linamarin, a cyanogenic glycoside that can release hydrogen cyanide upon enzymatic hydrolysis; thorough cooking effectively degrades this compound and is essential before consumption. Individuals taking antihypertensive medications, particularly ACE inhibitors such as lisinopril or enalapril, should exercise caution if consuming concentrated lima bean peptide extracts, as additive blood pressure-lowering effects are theoretically possible though unconfirmed in humans. Lima beans are a known legume allergen and may trigger allergic reactions in individuals sensitized to other Fabaceae family members, including cross-reactivity concerns. Sufficient safety data during pregnancy and lactation for concentrated extracts or supplements is lacking, and standard culinary use is generally considered safe within normal dietary amounts.